GPRC5A通过调节上皮间质转换促进胃癌细胞迁移和侵袭

来源 :2019中国肿瘤学大会 | 被引量 : 0次 | 上传用户：sunshineaigeng

【摘要】

：

目的 GPRC5A(G Protein-coupled receptor class C group 5 member A,又称G 蛋白偶联受体C家族5A)是G 蛋白偶联受体超家族的成员。研究证实其在肺癌的发生发展中起到很重要的抑癌基因作用。近年来越来越多的研究发现,GPRC5A 在除了肺癌的许多肿瘤中表达异常。然而,其在胃癌中的作用还没有被探索过。

【作者】

：

姜晓侠徐馨徐珍珍杨艳王浩浩王海勇俞雄飞滕理送

【机构】

：

浙江大学医学院附属第一医院

【出处】

：

2019中国肿瘤学大会

【发表日期】

：

2019年7期

【关键词】

：

G蛋白偶联受体C家族5A 胃癌肿瘤数据库预后上皮间质转换分子标志物

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Mir-16a/adrb2通过MAPK/Erk调节肝癌复发转移的机制研究

目的肝癌复发转移是当前肝癌治疗的重大难题,G蛋白偶联受体超家族(GPCR)是肝癌治疗的研究热点,与肿瘤的发生发展、代谢性疾病等重大疾病的主要机制息息相关。肾上腺素受体(ADR)是一种重要的GPCR 蛋白,ADR 信号通路在肿瘤复发转移中发挥着关键作用,研究表明β 2 肾上腺素受体(ADRB2)是肝癌细胞表面最重要的ADR,本研究拟聚焦于ADRB2 信号受体通路,阐明ADR2信号通路(β 2-AR

会议

肝癌β2受体复发转移

Cul4 E3 Ubiquitin Ligase Regulates Ovarian Cancer Drug Resistance by Targeting the Anti-apoptotic Pr

Objective Purpose: The failure of cancer chemotherapy is mostly caused by the development of drug resistance.In addition to the extensive genetic and epigenetic alterations in cancer cells,cancer cell

会议

ubiquitin ligasechemotherapyovarian cancerapoptosisdrug resistance

MIAT long noncoding RNA functions as a competing endogenous RNA to upregulate EZH2 by sponging miR-1

Objective While long noncoding RNAs(lncRNAs)have been reported to play an important role in regulating the pathological process of several human cancer types,they remain poorly understood in papillary

会议

Papillary thyroid carcinomaLong noncoding RNAceRNAMIATEZH2

Transcriptomic changes associated with PCK1 overexpression in hepatocellular carcinoma cells detecte

Objective Liver cancer is the fourth cause of cancer death worldwide in 2018,with about 841,000 new cases and 782,000 deaths annually.Hepatocellular carcinoma(HCC)comprises 75%-85%of primary liver can

会议

phosphoenolpyruvate carboxylase kinase1 (PCK1)hepatocellular carcinoma cellsRN

Identification of GSTP1 transferred by extracellular vesicles responsible for adriamycin-resistance

Objective Background: Chemo-resistance remains a major challenge for the successful treatment of breast cancer(BCa),and greatly affects clinical outcomes and overall survival in BCa patients.

会议

breast cancerexosomesdrug-resistance

扶正抗癌方联合吉非替尼对A549细胞的协同抗癌作用及机制研究

目的通过体外体内实验观察扶正抗癌(FZKA)方联合吉非替尼(Gefitinib)对人肺腺癌A549 细胞增殖，凋亡及侵袭转移能力的影响，并探讨研究其相关作用机制。

会议

扶正抗癌方吉非替尼协同作用F-盒和含蛋白7的WD重复结构域(FBW7)/髓样细胞白血病-1(MCL-1)

Paraspeckle participates in IL-6-induced HCC progression by nuclear retention of PRDX5 and GSTP1

Objective Paraspeckle is a kind of highly structured and organized nonmembranous nuclear body.lncRNA-nuclear paraspeckle assembly transcript 1(NEAT1)is essential for assembling of paraspeckles,acting

会议

paraspeckleinflammationinterlunkin-6hepatocellular carcinomaNEAT1

Role of Nanog by ERK1/2 signaling in CD44(+)cancer stem-like cell phenotypes in Epithelial-to-Mesenc

Objective Head and neck squamous cell carcinomas(HNSCC)may harbor a subset of cells with CD44(+)populations,including malignancy and radiotherapy resistance,and CD44 is one of a head and neck squamous

会议

Nanogcancer stem cellCD44ERK1/2EMThead and neck squamous cell carcinomas

Non-N-glycosylated BST-2 induced by hepatitis B virus promotes hepatocellular carcinoma

Objective Host cells respond to hepatitis B virus(HBV)infections by activating immune response genes that are not only involved in viral restriction,but may also result in hepatocellular carcinoma(HCC

会议

Hepatocellular CarcinomaBST-2Hepatitis B Virusnon-N-glycosylationNF-κ B/ERK

MUC-2调控IL-6分泌增加对结肠癌发生和转移的相关进展

目的本文旨在阐述MUC 2 调控IL-6 过表达与结肠癌发生和转移相关的研究进展，分析其中的作用机制与关联，为临床提供更多的参考。综述MUC-2 调控IL-6 分泌增加对结肠癌发生和转移的相关进展方法粘蛋白2(MUC 2)是结肠中分泌的主要黏液蛋白，在腺瘤和粘液癌中均有表达。

会议

结肠癌白细胞介素-6粘蛋白2转移治疗效果

GPRC5A通过调节上皮间质转换促进胃癌细胞迁移和侵袭

与本文相关的学术论文